Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Brekelmans MP, Bleker SM, Bauersachs R, Boda Z, Büller HR, Choi Y, Gallus A, Grosso MA, Middeldorp S, Oh D, Raskob G, Schwocho L, Cohen AT.
Brekelmans MP, et al. Among authors: choi y.
Thromb Haemost. 2016 Jul 4;116(1):155-61. doi: 10.1160/TH15-11-0892. Epub 2016 Mar 24.
Thromb Haemost. 2016.
PMID: 27010092
Clinical Trial.